Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
IP Group plc ( (GB:IPO) ) has shared an announcement.
IP Group plc has released 168,957 ordinary shares under its employee share schemes, delivering deferred bonus awards to its executive directors and a senior manager tied to partially deferred annual bonuses for the 2023 and 2024 financial years. The awards, valued at about £107,626 at an average price of 63.7p per share, were satisfied via the company’s employee benefit trust, with tax liabilities settled in cash, and the directors’ shares retained in trust to support the group’s post-cessation shareholding policy, leaving 883,427,642 shares in issue and none in treasury.
The move underscores IP Group’s continued use of equity-based incentives to align senior management with shareholder interests while reinforcing long-term ownership requirements for top executives. By structuring bonuses as deferred share awards and maintaining holdings through an employee benefit trust, the company signals a focus on governance, retention and long-term value creation for stakeholders in its science and innovation investment portfolio.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £110.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
Spark’s Take on IPO Stock
According to Spark, TipRanks’ AI Analyst, IPO is a Neutral.
The score is held back primarily by volatile operating performance and weak, inconsistent cash generation despite a 2025 profitability rebound. This is partially offset by a resilient balance sheet, constructive price momentum above key moving averages, and a relatively low P/E valuation.
To see Spark’s full report on IPO stock, click here.
More about IP Group plc
IP Group plc is a UK-based early-stage science and technology investor that backs breakthrough innovation in healthtech, deeptech and cleantech. Through its own balance sheet and via Parkwalk, the UK’s largest growth EIS fund manager, the group supports spinouts and high-growth ventures from leading universities and research institutions, and is listed on the London Stock Exchange under the ticker IPO.
Average Trading Volume: 3,745,503
Technical Sentiment Signal: Buy
Current Market Cap: £556.6M
For a thorough assessment of IPO stock, go to TipRanks’ Stock Analysis page.